P1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY

por Kuruvilla, J., Armand, P., Herrera, A. F., Ribrag, V., Brice, P., Thieblemont, C., Von Tresckow, B., Kim, E., Marinello, P., Chakraborty, S., Orlowski, R., Zinzani, P. L.
Publicado 2022

Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

por Oki, Y, Buglio, D, Zhang, J, Ying, Y, Zhou, S, Sureda, A, Ben-Yehuda, D, Zinzani, P L, Prince, H M, Harrison, S J, Kirschbaum, M, Johnston, P B, Shen, A, von Tresckow, B, Younes, A
Publicado 2014

P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY

por Derigs, P., Bethge, W., Holtick, U., von Tresckow, B., Ayuk, F., Penack, O., Vucinic, V., von Bonin, M., Baldus, C., Mougiakakos, D., Wulf, G., Schnetzke, U., Stelljes, M., Thomas, S., Schroers, R., Kroeger, N., Dreger, P.
Publicado 2022